Clinical trial
Initiation of a Once Daily Regimen of Tenofovir, Lamivudine and Efavirenz After 4 Weeks Versus 12 Weeks of Tuberculosis Treatment in HIV-1 Infected Patients (Time Study)
NCT01014481 is registered in ClinicalTrials.gov with Bamrasnaradura Infectious Diseases Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Initiation of a Once Daily Regimen of Tenofovir, Lamivudine and Efavirenz After 4 Weeks Versus 12 Weeks of Tuberculosis Treatment in HIV-1 Infected Patients (Time Study)
- Lead sponsor
- Bamrasnaradura Infectious Diseases Institute
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 31, 2009
- Completion date
- May 31, 2011
- Enrollment
- 156 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.